DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Martín M, Barrios CH, Torrecillas L. et al.
Efficacy results from CIBOMA/2004-01_GEICAM/2003-11 study: A randomized phase III trial assessing adjuvant capecitabine after standard chemotherapy for patients with early triple negative breast cancer.
San Antonio Breast Cancer Symposium; 2018 Abstr. GS2-04
Access:
We do not assume any responsibility for the contents of the web pages of other providers.